The Open Anesthesia Journal · 2019 · 14 citations · 33 references
MedicineAnesthesiologyPharmacologyAnesthesiaClinical PharmacologyGeneral AnesthesiaAirway AssessmentAirway ManagementEndotracheal IntubationSedation In Ventilated PatientsSedative PharmacologyAirway Management MedicationsAwake Tracheal IntubationClinical Practice Guidelines ImplementationDexmedetomidine AnalgesiaDexmedetomidine PharmacologyIntubating ConditionsPatient ComfortSedation For Intubation
Awake Fibreoptic Intubation (AFOI) is, nowadays, the gold standard in predicted difficult airway management. Numerous practice guidelines have been developed to assist clinicians facing with a difficult airway. If conducted without sedation, it is common that this procedure may lead to high patient discomfort and severe hemodynamic responses. Sedation is frequently used to make the process more tolerable to patients even if it is not always easy to strike a balance between patient comfort, safety, co-operation, and good intubating conditions. In the last years, many drugs and drug combinations have been described. This minireview aims to discuss the evidence supporting the use of Dexmedetomidine (DEX) in the AFOI management.
33
The Effects of Increasing Plasma Concentrations of Dexmedetomidine in Humans
Thomas J. Ebert, Judith Hall, Jill A. Barney et al. · Anesthesiology · 2000 · 1.4K citations · Full text
Effects of Intravenous Dexmedetomidine in Humans
B. C. Bloor, Denham S. Ward, Jon P. Belleville et al. · Anesthesiology · 1992 · 735 citations · Full text